Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

JAVELIN PHARMACEUTICALS, INC (JAV)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-09Dec-31-08Dec-31-07Dec-31-06Dec-31-05Dec-31-04Dec-31-03
   10-K10-K10-K10-K10-K10-K/A10-K
Revenues   [+]3,820.11,101.619.00.87.24.82,216.4
            Revenue growth  246.8%5692.2%2158.3%-88.3%50.1%-99.8% 
Cost of goods sold  2,978.7849.638.010.95.74.01,114.0
Gross profit  841.4252.0-19.0-10.01.50.81,102.4
            Gross margin  22.0%22.9%-100.0%-1188.8%21.5%17.4%49.7%
Selling, general and administrative   [+]13,248.617,219.513.89.65.22.72,013.4
Other operating expenses  24,489.026,830.6  7.24.82,216.4
EBITDA   [+]-37,217.9-44,091.3-32.8-19.6-10.9-6.7-3,151.8
            EBITDA margin  -974.3%-4002.4%-172.6%-2329.8%-150.9%-138.8%-142.2%
Depreciation and amortization  0.30.30.10.10.00.00.0
EBIT   [+]-37,218.2-44,091.6-32.9-19.7-10.9-6.7-3,151.8
            EBIT margin  -974.3%-4002.5%-173.1%-2337.0%-151.6%-139.5%-142.2%
Interest income, net   [+]49.7921.21.91.30.3-0.3-3.3
Other income (expense), net  -397.1-276.2 0.6 0.0 
Pre-tax income  -37,565.6-43,446.6-31.0-17.8-10.6-7.0-3,155.1
Income taxes  11.816.50.00.00.00.00.0
            Tax rate    0.0%0.0%0.0%0.0%0.0%
Net income  -37.6-43.50.00.00.00.0-3.2
            Net margin  -1.0%-3.9%-0.2%-2.1%-0.1%-0.1%-0.1%
   
Basic EPS   [+]($0.62)($0.77)($0.68)($0.44)($0.38)$0.00($0.32)
Diluted EPS   [+]($0.62)($0.77)($0.68)($0.44)($0.38)$0.00($0.32)
   
Shares outstanding (basic)   [+]61.056.20.00.00.010,936.99.9
Shares outstanding (diluted)   [+]61.056.20.00.00.010,936.99.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy